HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Investment analysts at Northland Capmk raised their FY2026 earnings per share (EPS) estimates for shares of HIVE Blockchain Technologies in a research note issued to investors on Tuesday, December 10th. Northland Capmk analyst M. Grondahl now expects that the company will post earnings per share of $0.16 for the year, up from their prior estimate of $0.15. Northland Capmk currently has a “Strong-Buy” rating on the stock.
Several other equities analysts have also issued reports on HIV. Cantor Fitzgerald raised HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Tuesday, October 29th. HC Wainwright upgraded HIVE Blockchain Technologies from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 15th.
HIVE Blockchain Technologies Price Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Featured Stories
- Five stocks we like better than HIVE Blockchain Technologies
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- Technology Stocks Explained: Here’s What to Know About Tech
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- What Makes a Stock a Good Dividend Stock?
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
